{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T05:24:44Z","timestamp":1788326684607,"version":"build-2803163510"},"reference-count":47,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","award":["IFA12\/LSBM-46"],"award-info":[{"award-number":["IFA12\/LSBM-46"]}],"id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Human Immunology"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.humimm.2024.111104","type":"journal-article","created":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T16:38:47Z","timestamp":1725899927000},"page":"111104","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Elevated toll-like receptor 9 is associated with disease severity and kidney involvement in systemic lupus erythematosus"],"prefix":"10.1016","volume":"85","author":[{"given":"Abhijit","family":"Pati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bidyut K.","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aditya K.","family":"Panda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.humimm.2024.111104_b0005","article-title":"Systemic lupus erythematosus: a review","author":"Siegel","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/j.humimm.2024.111104_b0010","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1136\/ard-2022-223741","article-title":"Pathogenesis of systemic lupus erythematosus: risks, mechanisms and therapeutic targets","volume":"82","author":"Crow","year":"2023","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.humimm.2024.111104_b0015","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2013.00010","article-title":"The linkage of innate and adaptive immune response during granulomatous development","volume":"4","author":"Ito","year":"2013","journal-title":"Front. Immunol."},{"key":"10.1016\/j.humimm.2024.111104_b0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2019.109122","article-title":"Current mechanistic insights into the role of infection in systemic lupus erythematosus","volume":"117","author":"Pan","year":"2019","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.humimm.2024.111104_b0025","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.cell.2020.02.041","article-title":"Toll-like receptors and the control of immunity","volume":"180","author":"Fitzgerald","year":"2020","journal-title":"Cell"},{"key":"10.1016\/j.humimm.2024.111104_b0030","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1038\/aps.2015.91","article-title":"Tang W, Zuo J-p: Toll-like receptors: potential targets for lupus treatment","volume":"36","author":"Wu","year":"2015","journal-title":"Acta. Pharmacol. Sin."},{"key":"10.1016\/j.humimm.2024.111104_b0035","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.4110\/in.2021.21.e18","article-title":"Toll-like receptor 2 in autoimmune inflammation","volume":"21","author":"Marks","year":"2021","journal-title":"Immune. Netw."},{"key":"10.1016\/j.humimm.2024.111104_b0040","article-title":"Signaling via TLR2 and TLR4 directly down-regulates T cell effector functions: the regulatory face of danger signals","volume":"4","author":"Cohen","year":"2013","journal-title":"Front. Immunol."},{"key":"10.1016\/j.humimm.2024.111104_b0045","doi-asserted-by":"crossref","first-page":"3311","DOI":"10.1002\/eji.200737744","article-title":"Toll-like receptors\u2019 two-edged sword: when immunity meets apoptosis","volume":"37","author":"Salaun","year":"2007","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.humimm.2024.111104_b0050","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1083\/jcb.201004096","article-title":"Clearance of apoptotic cells: implications in health and disease","volume":"189","author":"Elliott","year":"2010","journal-title":"J. Cell. Biol."},{"key":"10.1016\/j.humimm.2024.111104_b0055","doi-asserted-by":"crossref","first-page":"1093208","DOI":"10.3389\/fimmu.2023.1093208","article-title":"Toll-like receptors 7 and 9 regulate the proliferation and differentiation of B cells in systemic lupus erythematosus","volume":"14","author":"Wen","year":"2023","journal-title":"Front. Immunol"},{"key":"10.1016\/j.humimm.2024.111104_b0060","doi-asserted-by":"crossref","first-page":"15319","DOI":"10.1074\/jbc.R700009200","article-title":"Toll-like Receptors and Type I Interferons*","volume":"282","author":"Uematsu","year":"2007","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.humimm.2024.111104_b0065","doi-asserted-by":"crossref","first-page":"1259989","DOI":"10.3389\/fimmu.2023.1259989","article-title":"Surface toll-like receptor 9 on immune cells and its immunomodulatory effect","volume":"14","author":"Kou","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.humimm.2024.111104_b0070","doi-asserted-by":"crossref","first-page":"5219","DOI":"10.4049\/jimmunol.181.8.5219","article-title":"Activation of human plasmacytoid dendritic cells by TLR9 impairs Fc\u03b3RII-mediated uptake of immune complexes and presentation by MHC class II","volume":"181","author":"Benitez-Ribas","year":"2008","journal-title":"J. Immunol."},{"key":"10.1016\/j.humimm.2024.111104_b0075","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1007\/s10875-013-9887-0","article-title":"Distinct autoantibody profiles in systemic lupus erythematosus patients are selectively associated with TLR7 and TLR9 upregulation","volume":"33","author":"Chauhan","year":"2013","journal-title":"J. Clin. Immunol."},{"key":"10.1016\/j.humimm.2024.111104_b0080","doi-asserted-by":"crossref","unstructured":"Panda AK, Ravindran B, Das BK. Rheumatoid arthritis patients are free of filarial infection in an area where filariasis is endemic: comment on the article by Pineda et al. Arthritis Rheum 2013;65:1402.","DOI":"10.1002\/art.37883"},{"key":"10.1016\/j.humimm.2024.111104_b0085","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1093\/infdis\/jir258","article-title":"Human lymphatic filariasis: genetic polymorphism of endothelin-1 and tumor necrosis factor receptor II correlates with development of chronic disease","volume":"204","author":"Panda","year":"2011","journal-title":"J. Infect. Dis"},{"key":"10.1016\/j.humimm.2024.111104_b0090","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1177\/0961203314546019","article-title":"Absence of filarial infection in patients of systemic lupus erythematosus (SLE) in filarial endemic area: a possible protective role","volume":"23","author":"Panda","year":"2014","journal-title":"Lupus"},{"key":"10.1016\/j.humimm.2024.111104_b0095","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.4049\/jimmunol.175.2.1170","article-title":"Diminished expression and function of TLR in lymphatic filariasis: a novel mechanism of immune dysregulation","volume":"175","author":"Babu","year":"2005","journal-title":"J. Immunol"},{"key":"10.1016\/j.humimm.2024.111104_b0100","doi-asserted-by":"crossref","first-page":"3885","DOI":"10.4049\/jimmunol.176.7.3885","article-title":"Cutting edge: diminished T cell TLR expression and function modulates the immune response in human filarial infection","volume":"176","author":"Babu","year":"2006","journal-title":"J. Immunol"},{"key":"10.1016\/j.humimm.2024.111104_b0105","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1007\/s12026-008-8079-0","article-title":"Activation and regulation of toll-like receptors (TLRs) by helminth parasites","volume":"43","author":"Venugopal","year":"2009","journal-title":"Immunol. Res"},{"key":"10.1016\/j.humimm.2024.111104_b0110","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s11926-020-00896-6","article-title":"New criteria for lupus","volume":"22","author":"Aringer","year":"2020","journal-title":"Curr. Rheumatol. Rep"},{"key":"10.1016\/j.humimm.2024.111104_b0115","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/j.1365-2249.2008.03646.x","article-title":"Up-regulated expression of Toll-like receptors mRNAs in peripheral blood mononuclear cells from patients with systemic lupus erythematosus","volume":"152","author":"Komatsuda","year":"2008","journal-title":"Clin. Exp. Immunol"},{"key":"10.1016\/j.humimm.2024.111104_b0120","doi-asserted-by":"crossref","first-page":"973","DOI":"10.33549\/physiolres.934167","article-title":"Expression level of TLR9, but not hypomethylation, is correlated with SLE disease activity","volume":"68","author":"Li","year":"2019","journal-title":"Physiol. Res."},{"key":"10.1016\/j.humimm.2024.111104_b0125","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1369\/0022155417709234","article-title":"The Increased Expression of Toll-Like Receptor 4 in Renal and Skin Lesions in Lupus Erythematosus","volume":"65","author":"Elloumi","year":"2017","journal-title":"J. Histochem. Cytochem"},{"key":"10.1016\/j.humimm.2024.111104_b0130","doi-asserted-by":"crossref","first-page":"411","DOI":"10.3109\/09546634.2012.697110","article-title":"Toll-like receptor 9 in systemic lupus erythematosus, impact on glucocorticoid treatment","volume":"24","author":"Ghaly","year":"2013","journal-title":"J. Dermatolog. Treat"},{"key":"10.1016\/j.humimm.2024.111104_b0135","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.molimm.2014.05.001","article-title":"Increased expression of Toll-like receptors (TLRs) 7 and 9 and other cytokines in systemic lupus erythematosus (SLE) patients: ethnic differences and potential new targets for therapeutic drugs","volume":"61","author":"Lyn-Cook","year":"2014","journal-title":"Mol. Immunol"},{"key":"10.1016\/j.humimm.2024.111104_b0140","first-page":"493","article-title":"Toll-like receptor expression in lupus peripheral blood mononuclear cells","volume":"34","author":"Migita","year":"2007","journal-title":"J. Rheumatol"},{"key":"10.1016\/j.humimm.2024.111104_b0145","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1080\/08923973.2016.1263859","article-title":"Evaluation of TLR9 expression on PBMCs and CpG ODN-TLR9 ligation on IFN-\u03b1 production in SLE patients","volume":"39","author":"Mortezagholi","year":"2017","journal-title":"Immunopharmacol. Immunotoxicol"},{"key":"10.1016\/j.humimm.2024.111104_b0150","doi-asserted-by":"crossref","first-page":"3601","DOI":"10.1002\/art.22197","article-title":"Expansion of toll-like receptor 9-expressing B cells in active systemic lupus erythematosus: implications for the induction and maintenance of the autoimmune process","volume":"54","author":"Papadimitraki","year":"2006","journal-title":"Arthritis. Rheum"},{"key":"10.1016\/j.humimm.2024.111104_b0155","doi-asserted-by":"crossref","DOI":"10.1155\/2015\/710720","article-title":"Correlation between TLR9 Expression and Cytokine Secretion in the Clinical Diagnosis of Systemic Lupus Erythematosus","volume":"2015","author":"Rao","year":"2015","journal-title":"Mediators. Inflamm"},{"key":"10.1016\/j.humimm.2024.111104_b0160","first-page":"6830366","article-title":"The Effect of TLR9, MyD88, and NF-\u03baB p65 in Systemic Lupus Erythematosus","volume":"2022","author":"Wang","year":"2022","journal-title":"Evid. Based. Complement. Alternat. Med"},{"key":"10.1016\/j.humimm.2024.111104_b0165","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1016\/j.imbio.2008.10.004","article-title":"The expressions of Toll-like receptor 9 and T-bet in circulating B and T cells in newly diagnosed, untreated systemic lupus erythematosus and correlations with disease activity and laboratory data in a Chinese population","volume":"214","author":"Wu","year":"2009","journal-title":"Immunobiology"},{"key":"10.1016\/j.humimm.2024.111104_b0170","first-page":"3247","article-title":"Association of toll-like receptor 9 expression with prognosis of systemic lupus erythematosus","volume":"17","author":"Yuan","year":"2019","journal-title":"Exp. Ther. Med"},{"key":"10.1016\/j.humimm.2024.111104_b0175","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1365-2249.2009.04036.x","article-title":"Activation profile of Toll-like receptors of peripheral blood lymphocytes in patients with systemic lupus erythematosus","volume":"159","author":"Wong","year":"2010","journal-title":"Clin. Exp. Immunol"},{"key":"10.1016\/j.humimm.2024.111104_b0180","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.3389\/fimmu.2019.01243","article-title":"High TLR7 Expression Drives the Expansion of CD19(+)CD24(hi)CD38(hi) Transitional B Cells and Autoantibody Production in SLE Patients","volume":"10","author":"Wang","year":"2019","journal-title":"Front. Immunol"},{"key":"10.1016\/j.humimm.2024.111104_b0185","doi-asserted-by":"crossref","first-page":"7697592","DOI":"10.1155\/2016\/7697592","article-title":"Kidney expression of toll like receptors in lupus nephritis: quantification and clinicopathological correlations","volume":"2016","author":"Conti","year":"2016","journal-title":"Mediat. Inflamm"},{"key":"10.1016\/j.humimm.2024.111104_b0190","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.jbspin.2010.09.005","article-title":"Role for toll-like receptors in autoimmune disease: the example of systemic lupus erythematosus","volume":"78","author":"Richez","year":"2011","journal-title":"Joint. Bone. Spine"},{"key":"10.1016\/j.humimm.2024.111104_b0195","doi-asserted-by":"crossref","first-page":"2767","DOI":"10.1002\/art.24760","article-title":"Regression of systemic lupus erythematosus after development of an acquired toll-like receptor signaling defect and antibody deficiency","volume":"60","author":"Visentini","year":"2009","journal-title":"Arthritis. Rheum"},{"key":"10.1016\/j.humimm.2024.111104_b0200","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1002\/eji.201445219","article-title":"Increased expression of TLR2 in CD4(+) T cells from SLE patients enhances immune reactivity and promotes IL-17 expression through histone modifications","volume":"45","author":"Liu","year":"2015","journal-title":"Eur. J. Immunol"},{"key":"10.1016\/j.humimm.2024.111104_b0205","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1038\/ni1109-1139","article-title":"TLR2 joins the interferon gang","volume":"10","author":"Bauernfeind","year":"2009","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.humimm.2024.111104_b0210","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1111\/jcmm.12294","article-title":"A novel TLR2-triggered signalling crosstalk synergistically intensifies TNF-mediated IL-6 induction","volume":"18","author":"Chang","year":"2014","journal-title":"J. Cell. Mol. Med"},{"key":"10.1016\/j.humimm.2024.111104_b0215","article-title":"Inflammatory cytokines in systemic lupus erythematosus","volume":"2011","author":"Ohl","year":"2011","journal-title":"J. Biomed. Biotechnol"},{"key":"10.1016\/j.humimm.2024.111104_b0220","doi-asserted-by":"crossref","first-page":"A37","DOI":"10.1136\/ard.2010.148973.5","article-title":"Involvement of toll-like receptor 2 in pristane-induced lupus","volume":"70","author":"Vilma","year":"2011","journal-title":"Ann. Rheum. Dis."},{"key":"10.1016\/j.humimm.2024.111104_b0225","doi-asserted-by":"crossref","first-page":"9","DOI":"10.21037\/atm.2019.12.44","article-title":"Expression of HMGB1 and TLR4 in neuropsychiatric systemic lupus erythematosus patients with seizure disorders","volume":"8","author":"Huang","year":"2020","journal-title":"Ann. Transl. Med"},{"key":"10.1016\/j.humimm.2024.111104_b0230","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1111\/j.1365-3083.2010.02450.x","article-title":"Monocyte response to LPS after exposure to corticosteroids and chloroquine with implications for systemic lupus erythematosus","volume":"72","author":"Cepika","year":"2010","journal-title":"Scand. J. Immunol"},{"key":"10.1016\/j.humimm.2024.111104_b0235","doi-asserted-by":"crossref","first-page":"1703842","DOI":"10.1155\/2019\/1703842","article-title":"Correlations of Expression Levels of a Panel of Genes (IRF5, STAT4, TNFSF4, MECP2, and TLR7) and Cytokine Levels (IL-2, IL-6, IL-10, IL-12, IFN-\u03b3, and TNF-\u03b1) with Systemic Lupus Erythematosus Outcomes in Jordanian Patients","volume":"2019","author":"Uzrail","year":"2019","journal-title":"Biomed. Res. Int"}],"container-title":["Human Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885924003677?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0198885924003677?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,12,11]],"date-time":"2024-12-11T01:33:08Z","timestamp":1733880788000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0198885924003677"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":47,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S0198885924003677"],"URL":"https:\/\/doi.org\/10.1016\/j.humimm.2024.111104","relation":{},"ISSN":["0198-8859"],"issn-type":[{"value":"0198-8859","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Elevated toll-like receptor 9 is associated with disease severity and kidney involvement in systemic lupus erythematosus","name":"articletitle","label":"Article Title"},{"value":"Human Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.humimm.2024.111104","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 American Society for Histocompatibility and Immunogenetics. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"111104"}}